- Home
- OPTN vs SATL Comparison
OPTN vs SATL Comparison
Compare OPTN & SATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTN
- SATL
- Stock Information
- Founded
- OPTN 2010
- SATL 2010
- Country
- OPTN United States
- SATL Uruguay
- Employees
- OPTN N/A
- SATL N/A
- Industry
- OPTN Biotechnology: Pharmaceutical Preparations
- SATL Radio And Television Broadcasting And Communications Equipment
- Sector
- OPTN Health Care
- SATL Technology
- Exchange
- OPTN Nasdaq
- SATL Nasdaq
- Market Cap
- OPTN 99.7M
- SATL 95.7M
- IPO Year
- OPTN 2017
- SATL N/A
- Fundamental
- Price
- OPTN $0.46
- SATL $1.03
- Analyst Decision
- OPTN Strong Buy
- SATL
- Analyst Count
- OPTN 3
- SATL 0
- Target Price
- OPTN $3.00
- SATL N/A
- AVG Volume (30 Days)
- OPTN 617.5K
- SATL 67.0K
- Earning Date
- OPTN 11-12-2024
- SATL 11-26-2024
- Dividend Yield
- OPTN N/A
- SATL N/A
- EPS Growth
- OPTN N/A
- SATL N/A
- EPS
- OPTN N/A
- SATL N/A
- Revenue
- OPTN $75,672,000.00
- SATL $13,719,000.00
- Revenue This Year
- OPTN $24.44
- SATL N/A
- Revenue Next Year
- OPTN $49.00
- SATL N/A
- P/E Ratio
- OPTN N/A
- SATL N/A
- Revenue Growth
- OPTN 5.13
- SATL 101.51
- 52 Week Low
- OPTN $0.44
- SATL $0.71
- 52 Week High
- OPTN $2.10
- SATL $2.52
- Technical
- Relative Strength Index (RSI)
- OPTN 28.38
- SATL 54.00
- Support Level
- OPTN $0.50
- SATL $0.93
- Resistance Level
- OPTN $0.81
- SATL $1.09
- Average True Range (ATR)
- OPTN 0.06
- SATL 0.05
- MACD
- OPTN -0.02
- SATL 0.01
- Stochastic Oscillator
- OPTN 3.23
- SATL 53.12
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms, a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.
About SATL Satellogic Inc.
Satellogic Inc is a provider of satellite imagery to governments and commercial customers globally. It geographically operates in North America, Europe, Asia and South America. It derives maximum revenue from Asia Pacific.